(WZZM) Grand Rapids, Mich - The FDA approved a new drug for prostate cancer.
Specifically, the drug is for patients who have late stage cancer that has spread to their bones but not other organs, who have gone through surgery or who have tried therapies like hormone-based treatments.
Men taking the new drug during a clinical trial survived around five months longer than those taking a placebo.
There is a lot of research about prostate cancer being done right here in Michigan.
The University of Michigan is taking the lead on a study being done at 11 sites around the country.
Treatment would target the fusion of two genes that are believed to trigger prostate cancer discovered by U of M researchers in 2005.
Each study participant will undergo a biopsy looking for the gene fusion, which happens in about half of all prostate cancers.
All of the men in the study will undergo standard hormone based therapy, but only half will take an experimental drug designed to block an enzyme that interacts with gene fusion.
The study hopes to understand why some patients respond to therapy and others don't.
The University of Michigan is looking for study participants. If you're interested and would like more information click here.
Dr. Cindy Miranti, with the Van Andel Institute, has worked on prostate cancer research for years.
To see what Dr. Miranti has to say about her research and the condition itself watch the video link above.
Prostate cancer will affect on in every six men according to the American Cancer Society, and caught early it is often curable.